SAR-2022-032-JF


\newpage

Analytical Plan for Prevalence of knee implant loosening in patients with prior surgery in a German hospital

Document version

Version Alterations
01 Initial version

Abbreviations

Context

In SAR-2021-002-JF-v02 the average survival time of knee implants was estimated. After that retrospective cohort was analyzed, aggregated counts of previous surgery were made available, and this analysis will investigate whether or not this exposure is a significant risk factor for loosening.

Objectives

Calculate the prevalence of knee prosthesis loosening in patients with prior history of knee surgery in Helios Klinikum Berlin-Buch, Germany.

Hypotheses

Patients with prior knee surgery have a higher prevalence of implant loosening than controls.

Data

Raw data

The original data was already aggregated into counts of exposure and outcome. No individual information was available on these patients (see Observations).

Analytical dataset

N/A

Study parameters

Study design

This is a case-control study, based on hospital records.

Inclusion and exclusion criteria

N/A

Exposures

Exposure will be defined as having a previous knee surgery.

Outcomes

Specification of outcome measures (Zarin, 2011):

  1. (Domain) Knee arthroplasty
  2. (Specific measurement) Implant loosening
  3. (Specific metric) End value
  4. (Method of aggregation) Frequency of implant loosening

Primary outcome

Cases will be defined as the patient experienced a knee implant loosening event.

Covariates

N/A

Statistical methods

Statistical analyses

Descriptive analyses

The counts of exposures and outcomes will be described in frequency and proportion (%), and summarized in a 2x2 contingency table. Prevalence in exposed and unexposed will be reported.

Inferential analyses

The distributions of participants’ characteristics will be summarized in contingency tables. The measure of effect will be assessed with the OR. The measures of association between exposure and outcome will be assessed with the PR, as an additional measure. Both the point estimates and the CI around the estimates will be calculated using the Wald method.

Significance will be tested and interpreted from the Wald CI for all measures. Additionally the chi-squared test will be calculated for the OR, without Yates’ continuity correction.

Statistical modeling

N/A

Missing data

No missing data imputation will be performed. All evaluations will be performed as complete case analyses.

Significance and Confidence Intervals

All analyses will be performed using the significance level of 5%. All significance hypothesis tests and confidence intervals computed will be two-tailed.

Study size and Power

N/A

Statistical packages

This analysis will be performed using statistical software R version 4.2.1.

Observations and limitations

Aggregated sample data

No individual-level data was available for this analysis. This means that we cannot control for confounding either in regression models or stratified analyses. It is recommended that this be reported as a limitation of the study, since it raises the risk of bias of the study.

Recommended reporting guideline

The adoption of the EQUATOR network (http://www.equator-network.org/) reporting guidelines have seen increasing adoption by scientific journals. All observational studies are recommended to be reported following the STROBE guideline (von Elm et al, 2014).

In particular when a retrospective study is conducted using hospital records, it is recommended that the RECORD extension of the STROBE guideline is considered (Benchimol et al, 2015).

References

Appendix

This document was elaborated following recommendations on the structure for Statistical Analysis Plans (Gamble, 2017) for better transparency and clarity.

Associated analyses

This analysis is part of a larger project and is supported by other analyses, linked below.

Implant failure rates in a knee prosthesis sub-population of the Helios Klinikum Berlin-Buch hospitals

https://philsf-biostat.github.io/SAR-2021-002-JF/

Availability

All documents from this consultation were included in the consultant’s Portfolio.

The portfolio is available at:

https://philsf-biostat.github.io/SAR-2022-032-JF/